Search Within

Olivera Grbovic-Huezo

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (5)
Groups
  1. GSK Faculty (18)
  2. Human Oncology and Pathogenesis Program (18)
  3. Sloan Kettering Institute Postdocs (18)
  4. Department of Medicine (16)
  5. Sloan Kettering Institute Faculty (16)
  6. Solid Tumor Oncology Division (16)

More Groups

People
  1. Neal Rosen (14)
  2. David Solit (13)
  3. Christine Pratilas (9)
  4. Ayana Sawai (7)
  5. Andrea Basso (6)
  6. Christine Iacobuzio-Donahue (4)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2017 (2)
  4. 2011 (1)
  5. 2009 (1)
  6. 2007 (4)

More Years

Publications
  1. Cancer Research (8)
  2. Clinical Cancer Research (2)
  3. Proceedings of the National Academy of Sciences of the United States of America (2)
  4. Cancer Cell (1)
  5. EJC Supplements (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. National Academy of Sciences (2)
  3. American Society of Clinical Oncology (1)
  4. Biomed Central Ltd (1)
  5. Cell Press (1)
  6. Nature Publishing Group (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systematic comparison of pancreatic ductal adenocarcinoma models identifies a conserved highly plastic basal cell state
    Journal Article

    Pitter, K. L.; Grbovic-Huezo, O.; Joost, S.; Singhal, A.; Blum, M.; Wu, K.; Holm, M.; Ferrena, A.; Bhutkar, A.; Hudson, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma
    Journal Article

    Grbovic-Huezo, O.; Pitter, K. L.; Lecomte, N.; Saglimbeni, J.; Askan, G.; Holm, M.; Melchor, J. P.; Chandwani, R.; Joshi, S.; Haglund, C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2020)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term pancreatic cancer survivors
    Meeting Abstract

    Balachandran, V.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
    Journal Article

    Balachandran, V. P.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Nature (2017)

    Fulltext@MSK | Save
  • AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity
    Journal Article

    Chandarlapaty, S.; Sawai, A.; Scaltriti, M.; Rodrik-Outmezguine, V. ; Grbovic-Huezo, O.; Serra, V.; Majumder, P. K.; Baselga, J.; Rosen, N.
    Cancer Cell (2011)

    Fulltext@MSK | Save
  • Amplification of wild-type BRAF in melanoma is associated with activation of RAF-MEK-ERK signaling and MEK-dependence
    Meeting Abstract

    Blumenthal, E.; Poulikakos, P. I.; Tadi, M.; Grbovic-Huezo, O.; Taylor, B. S.; Janakiraman, M.; Leversha, M.; Viale, A.; Solit, D. B.; Rosen, N.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Sawai, A.; Grbovic-Huezo, O.; Rosen, N.; Solit, D. B.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Activating mutation in B-RAF disables normal feedback inhibition of MEK and results in increased output of the RAF/MEK/MAPK signaling pathway
    Meeting Abstract

    Pratilas, C. A.; Taylor, B.; Nelander, S.; Grbovic-Huezo, O.; Viale, A.; Solit, D.; Sander, C.; Rosen, N.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • BRAF mutation predicts for MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Halilovic, E.; Pratilas, C.; Sawai, A.; Grbovic, O.; Rosen, N.; Solit, D. B.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Persaud, Y.; Sawai, A.; Grbovic-Huezo, O.; Janakiraman, M.; Rosen, N.; Solit, D. B.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save